-
1
-
-
11144285626
-
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
-
Li J, Nation RL, Milne RW, Turnidge JD, Coulthard K. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2005;25(1):11-25.
-
(2005)
Int J Antimicrob Agents
, vol.25
, Issue.1
, pp. 11-25
-
-
Li, J.1
Nation, R.L.2
Milne, R.W.3
Turnidge, J.D.4
Coulthard, K.5
-
2
-
-
0015999159
-
Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B
-
Duncan IB. Susceptibility of 1,500 isolates of Pseudomonas aeruginosa to gentamicin, carbenicillin, colistin, and polymyxin B. Antimicrob Agents Chemother. 1974;5(1):9-15.
-
(1974)
Antimicrob Agents Chemother
, vol.5
, Issue.1
, pp. 9-15
-
-
Duncan, I.B.1
-
3
-
-
0014801502
-
Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy
-
Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC, Eaton AE. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 1970;72(6):857-868.
-
(1970)
Ann Intern Med
, vol.72
, Issue.6
, pp. 857-868
-
-
Koch-Weser, J.1
Sidel, V.W.2
Federman, E.B.3
Kanarek, P.4
Finer, D.C.5
Eaton, A.E.6
-
4
-
-
0013964173
-
Acute renal failure associated with sodium colistimethate treatment
-
Elwood CM, Lucas GD, Muehrcke RC. Acute renal failure associated with sodium colistimethate treatment. Arch Intern Med. 1966;118(4):326-334.
-
(1966)
Arch Intern Med
, vol.118
, Issue.4
, pp. 326-334
-
-
Elwood, C.M.1
Lucas, G.D.2
Muehrcke, R.C.3
-
5
-
-
0014966476
-
Effects of large doses of colistin sulphomethate sodium on renal function
-
Price DJ, Graham DI. Effects of large doses of colistin sulphomethate sodium on renal function. BMJ. 1970;4(5734):525-527.
-
(1970)
BMJ
, vol.4
, Issue.5734
, pp. 525-527
-
-
Price, D.J.1
Graham, D.I.2
-
7
-
-
33744454666
-
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa
-
Bergen PJ, Li J, Rayner CR, Nation RL. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2006;50(6):1953-1958.
-
(2006)
Antimicrob Agents Chemother
, vol.50
, Issue.6
, pp. 1953-1958
-
-
Bergen, P.J.1
Li, J.2
Rayner, C.R.3
Nation, R.L.4
-
8
-
-
0035118424
-
In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
-
Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 2001;45(3):781-785.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, Issue.3
, pp. 781-785
-
-
Li, J.1
Turnidge, J.2
Milne, R.3
Nation, R.L.4
Coulthard, K.5
-
9
-
-
0001526503
-
Serum concentration of colistin in patients with normal and impaired renal function
-
Mackay DN, Kaye D. Serum concentration of colistin in patients with normal and impaired renal function. N Engl J Med. 1964;270:394-397.
-
(1964)
N Engl J Med
, vol.270
, pp. 394-397
-
-
Mackay, D.N.1
Kaye, D.2
-
10
-
-
0014739503
-
Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals
-
Froman J, Gross L, Curatola S. Serum and urine levels following parenteral administration of sodium colistimethate to normal individuals. J Urol. 1970;103(2):210-214.
-
(1970)
J Urol
, vol.103
, Issue.2
, pp. 210-214
-
-
Froman, J.1
Gross, L.2
Curatola, S.3
-
11
-
-
0035949823
-
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversedphase high-performance liquid chromatography
-
Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Johnson DW. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversedphase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 2001;761(2):167-175.
-
(2001)
J Chromatogr B Biomed Sci Appl
, vol.761
, Issue.2
, pp. 167-175
-
-
Li, J.1
Milne, R.W.2
Nation, R.L.3
Turnidge, J.D.4
Coulthard, K.5
Johnson, D.W.6
-
12
-
-
0036784069
-
Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography
-
Li J, Milne RW, Nation RL, Turnidge JD, Coulthard K, Valentine J. Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography. Antimicrob Agents Chemother. 2002;46(10):3304-3307.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, Issue.10
, pp. 3304-3307
-
-
Li, J.1
Milne, R.W.2
Nation, R.L.3
Turnidge, J.D.4
Coulthard, K.5
Valentine, J.6
-
13
-
-
33747362870
-
Colistin: The re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
-
Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis. 2006;6(9):589-601.
-
(2006)
Lancet Infect Dis
, vol.6
, Issue.9
, pp. 589-601
-
-
Li, J.1
Nation, R.L.2
Turnidge, J.D.3
-
14
-
-
17644389620
-
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
-
Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis. 2005;40(9):1333-1341.
-
(2005)
Clin Infect Dis
, vol.40
, Issue.9
, pp. 1333-1341
-
-
Falagas, M.E.1
Kasiakou, S.K.2
-
15
-
-
0033674317
-
The treatment of respiratory pseudomonas infection in cystic fibrosis: What drug and which way?
-
Banerjee D, Stableforth D. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Drugs. 2000;60(5):1053-1064.
-
(2000)
Drugs
, vol.60
, Issue.5
, pp. 1053-1064
-
-
Banerjee, D.1
Stableforth, D.2
-
16
-
-
0348149151
-
Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis
-
Li J, Coulthard K, Milne R, et al. Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. J Antimicrob Chemother. 2003;52(6):987-992.
-
(2003)
J Antimicrob Chemother
, vol.52
, Issue.6
, pp. 987-992
-
-
Li, J.1
Coulthard, K.2
Milne, R.3
-
17
-
-
45149094778
-
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gramnegative bacilli infections: A prospective, open-label, uncontrolled study
-
Markou N, Markantonis SL, Dimitrakis E, et al. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gramnegative bacilli infections: a prospective, open-label, uncontrolled study. Clin Ther. 2008;30(1):143-151.
-
(2008)
Clin Ther
, vol.30
, Issue.1
, pp. 143-151
-
-
Markou, N.1
Markantonis, S.L.2
Dimitrakis, E.3
-
18
-
-
27644585168
-
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration
-
Li J, Rayner CR, Nation RL, et al. Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. Antimicrob Agents Chemother. 2005;49(11):4814- 4815.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, Issue.11
, pp. 4814-4815
-
-
Li, J.1
Rayner, C.R.2
Nation, R.L.3
-
19
-
-
67749145541
-
Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria
-
Plachouras D, Karvanen M, Friberg LE, et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. Antimicrob Agents Chemother. 2009;53(8):3430-3436.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, Issue.8
, pp. 3430-3436
-
-
Plachouras, D.1
Karvanen, M.2
Friberg, L.E.3
-
20
-
-
33744823760
-
The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients?
-
Pea F, Viale P. The antimicrobial therapy puzzle: could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? Clin Infect Dis. 2006;42(12):1764-1771.
-
(2006)
Clin Infect Dis
, vol.42
, Issue.12
, pp. 1764-1771
-
-
Pea, F.1
Viale, P.2
-
21
-
-
12944307865
-
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness
-
Mehrotra R, De Gaudio R, Palazzo M. Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness. Intensive Care Med. 2004;30(12):2145-2156.
-
(2004)
Intensive Care Med
, vol.30
, Issue.12
, pp. 2145-2156
-
-
Mehrotra, R.1
De Gaudio, R.2
Palazzo, M.3
-
22
-
-
0036233695
-
Intrapulmonary pharmacokinetics of linezolid
-
Conte JE Jr, Golden JA, Kipps J, Zurlinden E. Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother. 2002;46(5):1475- 1480.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, Issue.5
, pp. 1475-1480
-
-
Conte Jr., J.E.1
Golden, J.A.2
Kipps, J.3
Zurlinden, E.4
-
23
-
-
51549106318
-
Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients
-
Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Høiby N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros. 2008;7(5):391-397.
-
(2008)
J Cyst Fibros
, vol.7
, Issue.5
, pp. 391-397
-
-
Johansen, H.K.1
Moskowitz, S.M.2
Ciofu, O.3
Pressler, T.4
Høiby, N.5
-
24
-
-
40049095690
-
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: Studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
-
Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. J Antimicrob Chemother. 2008;61(3):636-642.
-
(2008)
J Antimicrob Chemother
, vol.61
, Issue.3
, pp. 636-642
-
-
Bergen, P.J.1
Li, J.2
Nation, R.L.3
Turnidge, J.D.4
Coulthard, K.5
Milne, R.W.6
-
25
-
-
77149178390
-
Elucidation of pharmacolinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in mutine thigh and lung infection model
-
Dudhani RV, Turnidge JD, Coulthard K, et al. Elucidation of pharmacolinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in mutine thigh and lung infection model. Antimicrob Agents Chemother. 2010;54(3):1117-1124.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.3
, pp. 1117-1124
-
-
Dudhani, R.V.1
Turnidge, J.D.2
Coulthard, K.3
-
26
-
-
24144457739
-
Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa
-
Tam VH, Schilling AN, Vo G, et al. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2005;49(9):3624-3630
-
(2005)
Antimicrob Agents Chemother
, vol.49
, Issue.9
, pp. 3624-3630
-
-
Tam, V.H.1
Schilling, A.N.2
Vo, G.3
-
27
-
-
45749155186
-
Intravenous colistimethate for multidrugresistant Gram-negative bacteria
-
Zavascki AP, Li J. Intravenous colistimethate for multidrugresistant Gram-negative bacteria. Lancet Infect Dis. 2008;8(7):403-405.
-
(2008)
Lancet Infect Dis
, vol.8
, Issue.7
, pp. 403-405
-
-
Zavascki, A.P.1
Li, J.2
-
28
-
-
23744504983
-
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: A prospective cohort study
-
Reina R, Estenssoro E, Sáenz G, et al. Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections: a prospective cohort study. Intensive Care Med. 2005;31(8):1058-1065.
-
(2005)
Intensive Care Med
, vol.31
, Issue.8
, pp. 1058-1065
-
-
Reina, R.1
Estenssoro, E.2
Sáenz, G.3
-
29
-
-
34447130382
-
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: A matched case-control study
-
Kallel H, HergafiL, Bahloul M, et al. Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study. Intensive Care Med. 2007;33(7):1162-1167.
-
(2007)
Intensive Care Med
, vol.33
, Issue.7
, pp. 1162-1167
-
-
Kallel, H.1
Hergafi, L.2
Bahloul, M.3
-
30
-
-
13844311296
-
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: The renaissance of an old antibiotic
-
Michalopoulos AS, Tsiodras S, Rellos K, Mentzelopoulos S, Falagas ME. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin Microbiol Infect. 2005;11(2):115-121.
-
(2005)
Clin Microbiol Infect
, vol.11
, Issue.2
, pp. 115-121
-
-
Michalopoulos, A.S.1
Tsiodras, S.2
Rellos, K.3
Mentzelopoulos, S.4
Falagas, M.E.5
-
31
-
-
23644439540
-
Eradication of early Pseudomonas aeruginosa infection
-
Høiby N, Frederiksen B, Pressler T. Eradication of early Pseudomonas aeruginosa infection. J Cyst Fibros. 2005;4(suppl 2):49-54.
-
(2005)
J Cyst Fibros
, vol.4
, Issue.SUPPL. 2
, pp. 49-54
-
-
Høiby, N.1
Frederiksen, B.2
Pressler, T.3
-
32
-
-
77955159963
-
Inhaled colistin as adjunctive to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: A comparative cohort study
-
Korbila IP, Michalopoulos A, Rafailidis PI, Nikita D, Samonis G, Falagas ME. Inhaled colistin as adjunctive to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Clin Microbiol Infect. 2010;16(8):1230-1236.
-
(2010)
Clin Microbiol Infect
, vol.16
, Issue.8
, pp. 1230-1236
-
-
Korbila, I.P.1
Michalopoulos, A.2
Rafailidis, P.I.3
Nikita, D.4
Samonis, G.5
Falagas, M.E.6
-
33
-
-
63149197646
-
Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: A case series
-
Falagas ME, Siempos II, Rafailidis PI, Korbila IP, Ioannidou E, Michalopoulos A. Inhaled colistin as monotherapy for multidrug-resistant gram (-) nosocomial pneumonia: a case series. Respir Med. 2009;103(5):707-713.
-
(2009)
Respir Med
, vol.103
, Issue.5
, pp. 707-713
-
-
Falagas, M.E.1
Siempos, I.I.2
Rafailidis, P.I.3
Korbila, I.P.4
Ioannidou, E.5
Michalopoulos, A.6
-
34
-
-
10344219968
-
Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use
-
Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol. 2005;39(1):15-20.
-
(2005)
Pediatr Pulmonol
, vol.39
, Issue.1
, pp. 15-20
-
-
Al-Aloul, M.1
Miller, H.2
Alapati, S.3
Stockton, P.A.4
Ledson, M.J.5
Walshaw, M.J.6
-
35
-
-
33747368398
-
Urinary N-acetyl-b-D-glucosaminidase (NAG) in adults with CF - A marker of nephrotoxicity?
-
abstract
-
Etherington C, Conway SP, Peckam DG, et al. Urinary N-acetyl-b-D- glucosaminidase (NAG) in adults with CF - A marker of nephrotoxicity [abstract] ? J Cyst Fibros. 2004;3 (suppl 1):S49.
-
(2004)
J Cyst Fibros
, vol.3
, Issue.SUPPL. 1
-
-
Etherington, C.1
Conway, S.P.2
Peckam, D.G.3
-
36
-
-
0015132070
-
Binding of polymyxin antibiotics to tissues: The major determinant of distribution and persistence in the body
-
Kunin CM, Bugg A. Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body. J Infect Dis. 1971;124(4):394-400.
-
(1971)
J Infect Dis
, vol.124
, Issue.4
, pp. 394-400
-
-
Kunin, C.M.1
Bugg, A.2
-
37
-
-
0020106810
-
The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves
-
Ziv G, Nouws JFM, van Ginneken CAM. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. J Vet Pharmacol Ther. 1982;5(1):45-58.
-
(1982)
J Vet Pharmacol Ther
, vol.5
, Issue.1
, pp. 45-58
-
-
Ziv, G.1
Nouws, J.F.M.2
Van Ginneken, C.A.M.3
|